An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease

Overview of attention for article published in Current Alzheimer Research, July 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#1 of 1,177)
High Attention Score compared to outputs of the same age (99th percentile)

Mentioned by

news: 61 news outlets
twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 82 Mendeley

Summary News X Patents Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

Focusing on mitochondria in the brain: from biology to therapeutics

Article in Translational Neurodegeneration (April 2024)

Glucose-derived glutamate drives neuronal terminal differentiation in vitro

Article in EMBO Reports (January 2024)

Insulin sensitizers in 2023: lessons learned and new avenues for investigation

Article in Expert Opinion on Investigational Drugs (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.